Some complaints point to shipping issues and delayed responses, but these seem less common than with other telehealth clinics
Animal studies have shown a low acute toxicity profile
sometimes increases in HDL Liver : Improvements in fatty liver disease (reduced liver fat, improved liver enzymes) Cardiovascular Improvements : Blood Pressure : Significant reductions in systolic and diastolic blood pressure Cardiovascular Events : According to SELECT trial (semaglutide), 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) Heart Function : Improvements in cardiac structure and function markers Physical Function Improvements : Mobility : Improved ability to walk, climb stairs, engage in physical activities Joint Pain : Reduced knee, hip, and back pain from decreased weight-bearing stress Sleep : Improvements in sleep quality
Semaglutide begins activating GLP-1 receptors within 3060 minutes of injection, but appetite suppression typically peaks 13 hours post-injection and remains elevated for 7 days
Dutta D, Bhattacharya S, Surana V, et al
Tirzepatide: Weight Loss: Clinical trials have shown that Tirzepatide can lead to weight loss of up to 20-25% of initial body weight, making it a strong competitor against Semaglutide